• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生活质量与帕金森病:帕金森病问卷的菲律宾语翻译及验证

Quality of life and Parkinson's disease: Philippine translation and validation of the Parkinson's disease questionnaire.

作者信息

Suratos Cezar Thomas R, Saranza Gerard Raimon M, Sumalapao Derick Erl P, Jamora Roland Dominic G

机构信息

Department of Neurosciences, College of Medicine - Philippine General Hospital, University of the Philippines Manila, Taft Avenue, Manila 1000, Philippines.

Department of Biology, College of Science, De La Salle University, Manila 1004, Philippines; Department of Medical Microbiology, College of Public Health, University of the Philippines Manila, Manila, 1000, Philippines.

出版信息

J Clin Neurosci. 2018 Aug;54:156-160. doi: 10.1016/j.jocn.2018.06.013. Epub 2018 Jun 12.

DOI:10.1016/j.jocn.2018.06.013
PMID:29907384
Abstract

The 39-item Parkinson's Disease Quality of Life Questionnaire (PDQ-39) is the most widely used self-administered questionnaire assessing the quality of life of Parkinson's disease (PD) patients. We translated the PDQ-39 into the Filipino language as the Philippine-PDQ-39 (P-PDQ-39) and used it to assess the quality of life of Filipino patients with PD. The original PDQ-39 was translated into Filipino using forward and backward translation by independent bilingual translators and used among 100 consecutively sampled PD patients. Baseline demographic data, disease duration and levodopa equivalent dose were collected. Internal consistency was measured using Chronbach's α. The following rating scales and questionnaires were correlated with P-PDQ-39 through Pearson's correlation coefficient to assess construct validity: modified Hoehn & Yahr Stage, Hospital Anxiety and Depression Scale-Pilipino (HADS-P), Unified Parkinson's Disease Rating Scale (UPDRS) Parts I-III, and Non-motor symptom Assessment Scale for Parkinson's Disease (NMSS). The mobility and activities of daily living domains of the P-PDQ-39 were well correlated with the Hoehn & Yahr stage of the patients and the UPDRS II and III scores emphasizing the value of motor symptoms in quality of life. Non motor symptoms in PD were also important determinants of quality of life as demonstrated in the correlation of HADS-P and NMSS Total scores with the P-PDQ 39 domains. The P-PDQ-39 is a valid assessment tool for assessing the quality of life of Filipino-speaking PD patients.

摘要

39项帕金森病生活质量问卷(PDQ - 39)是评估帕金森病(PD)患者生活质量时使用最广泛的自填式问卷。我们将PDQ - 39翻译成菲律宾语,即菲律宾 - PDQ - 39(P - PDQ - 39),并用它来评估菲律宾PD患者的生活质量。最初的PDQ - 39由独立的双语翻译人员通过正向和反向翻译翻译成菲律宾语,并在100例连续抽样的PD患者中使用。收集了基线人口统计学数据、病程和左旋多巴等效剂量。使用克朗巴赫α系数测量内部一致性。通过皮尔逊相关系数将以下评定量表和问卷与P - PDQ - 39相关联,以评估结构效度:改良的Hoehn & Yahr分期、菲律宾医院焦虑抑郁量表(HADS - P)、统一帕金森病评定量表(UPDRS)第一至三部分,以及帕金森病非运动症状评估量表(NMSS)。P - PDQ - 39的移动性和日常生活领域与患者的Hoehn & Yahr分期以及UPDRS II和III评分密切相关,强调了运动症状在生活质量中的价值。PD中的非运动症状也是生活质量的重要决定因素,这在HADS - P和NMSS总分与P - PDQ 39各领域的相关性中得到了体现。P - PDQ - 39是评估说菲律宾语的PD患者生活质量的有效评估工具。

相似文献

1
Quality of life and Parkinson's disease: Philippine translation and validation of the Parkinson's disease questionnaire.生活质量与帕金森病:帕金森病问卷的菲律宾语翻译及验证
J Clin Neurosci. 2018 Aug;54:156-160. doi: 10.1016/j.jocn.2018.06.013. Epub 2018 Jun 12.
2
Quality of life in Parkinson's disease: Greek translation and validation of the Parkinson's disease questionnaire (PDQ-39).帕金森病的生活质量:帕金森病问卷(PDQ - 39)的希腊语翻译与验证
Qual Life Res. 2001;10(2):159-63. doi: 10.1023/a:1016720400862.
3
Impact of non-motor symptoms on health-related and perceived quality of life in Parkinson's disease.帕金森病非运动症状对健康相关和感知生活质量的影响。
J Neurol Sci. 2013 Sep 15;332(1-2):136-40. doi: 10.1016/j.jns.2013.07.005. Epub 2013 Jul 25.
4
Beneficial effects of bilateral subthalamic stimulation on alexithymia in Parkinson's disease.双侧丘脑底核刺激对帕金森病患者述情障碍的有益影响。
Eur J Neurol. 2019 Feb;26(2):222-e17. doi: 10.1111/ene.13773. Epub 2018 Sep 21.
5
Validation of the Italian version of the Non Motor Symptoms Scale for Parkinson's disease.帕金森病非运动症状量表意大利语版本的验证
Parkinsonism Relat Disord. 2017 Jan;34:38-42. doi: 10.1016/j.parkreldis.2016.10.020. Epub 2016 Oct 24.
6
Translation and validation of the korean version of the 39-item Parkinson's disease questionnaire.帕金森病 39 项问卷韩文版的翻译与验证。
J Clin Neurol. 2013 Jan;9(1):26-31. doi: 10.3988/jcn.2013.9.1.26. Epub 2013 Jan 3.
7
Cost of Parkinson's disease among Filipino patients seen at a public tertiary hospital in Metro Manila.菲律宾马尼拉一家公立三级医院帕金森病患者的成本。
J Clin Neurosci. 2020 Apr;74:41-46. doi: 10.1016/j.jocn.2020.01.057. Epub 2020 Jan 23.
8
Clinical features and relative factors of constipation in a cohort of Chinese patients with Parkinson's disease.一组中国帕金森病患者便秘的临床特征及相关因素
World J Gastrointest Pharmacol Ther. 2021 Jan 5;12(1):21-31. doi: 10.4292/wjgpt.v12.i1.21.
9
Validation of the Korean version of the 39-Item Parkinson's Disease Questionnaire (PDQ-39).39项帕金森病问卷(PDQ-39)韩文版的验证
Asian Nurs Res (Korean Soc Nurs Sci). 2014 Mar;8(1):67-74. doi: 10.1016/j.anr.2014.02.004. Epub 2014 Mar 6.
10
The Key Determinants to Quality of Life in Parkinson's Disease Patients: Results from the Parkinson's Disease Biomarker Program (PDBP).帕金森病患者生活质量的关键决定因素:帕金森病生物标志物项目(PDBP)的结果。
J Parkinsons Dis. 2016 May 31;6(3):523-32. doi: 10.3233/JPD-160851.

引用本文的文献

1
Quality of life measures in Parkinson's disease: a systematic literature review of patient-reported outcomes measures (PROMs) and their psychometric properties.帕金森病的生活质量测量:患者报告结局测量指标(PROMs)及其心理测量特性的系统文献综述
J Neurol. 2025 Aug 28;272(9):598. doi: 10.1007/s00415-025-13348-x.
2
A Community-based study on the prevalence and predisposing factors of Parkinson's disease in Barangay Mangilag Sur, Quezon Province, Philippines.菲律宾奎松省芒吉拉格苏尔村基于社区的帕金森病患病率及诱发因素研究。
Clin Park Relat Disord. 2022 Oct 26;7:100169. doi: 10.1016/j.prdoa.2022.100169. eCollection 2022.